Doceree Expands Point-of-Care Reach with Care Sequence Platform — Doceree Inc.

Event summary

Doceree launched Care Sequence on August 20, 2026, enabling brands to activate messaging across all moments of a patient encounter from waiting room to pharmacy counter.
The platform triggers coordinated messaging to patients, physicians, and pharmacists based on a single verified clinical event.
Care Sequence is priced on a cost-per-sequence basis, charged once per qualified clinical visit rather than per touch.
The platform integrates with 185+ direct EHR and health-system integrations and 40,000+ pharmacies in the United States.

The big picture

Doceree's Care Sequence addresses a longstanding gap in healthcare marketing by enabling brands to engage with all stakeholders throughout the patient encounter. This move comes as pharmaceutical companies increasingly seek to optimize their marketing spend across the entire care continuum, from prescription to adherence. The platform's integration with a vast network of EHR systems and pharmacies positions it to become a significant player in the point-of-care advertising space.

What we're watching

Adoption Pace: How quickly pharmaceutical brands and agencies will integrate Care Sequence into their marketing strategies.
Measurement Impact: Whether the closed-loop measurement capabilities will drive more precise ROI tracking for point-of-care advertising.
Competitive Response: How existing healthcare marketing platforms will react to Doceree's expanded point-of-care capabilities.